RecruitingNCT05652023
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
Sponsor
Mayo Clinic
Enrollment
2,023 participants
Start Date
Apr 20, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with bph with urinary obstruction, bladder dysfunction, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 90 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05652023
Related Trials
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT0651114121 locations
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
NCT048730371 location
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
NCT058789511 location
Add-On ZIDA Sock Therapy for Overactive Bladder
NCT074326591 location
IMPACT OF DIALYSIS DURATION AND DIURESIS ON BLADDER CAPACITY AND COMPLIANCE IN END STAGE RENAL DISEASE PATIENTS AWAITING RENAL TRANSPLANT
NCT075707711 location